Andrew W. Mielach (Account Director) specializes in developing client media strategy based on agreed parameters and key messages. He focuses on national business media as well as regional and local media.

Prior to joining Tiberend Strategic Advisors, Inc., Mr. Mielach was as an Account Executive at Rx Mosaic Health where he coordinated media campaigns for Sepracor’s LUNESTA® and respiratory franchises. He additionally assisted in developing and executing media initiatives aimed at raising awareness among consumers, patients and physicians about Teva Neuroscience’s COPAXONE® and Phase III oral laquinimod, which is a once-daily novel oral immunomodulatory agent developed as a disease modifying treatment for multiple sclerosis.

Some of Mr. Mielach’s recent client story successes include articles in Forbes, Dow Jones Newswires, Thomson Reuters and Pharmawire. In addition, he has worked to generate clients' stories and management appearances on FOX, CNN, ABC, CBS, NBC and National Public Radio.

In order to provide the best client service and bring strategic ideas and opportunities to clients, Mr. Mielach continuously monitors news trends in the financial markets, healthcare and the political environment.

Mr. Mielach is a 2007 communications graduate of Seton Hall University.